606 related articles for article (PubMed ID: 17685448)
1. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
[TBL] [Abstract][Full Text] [Related]
3. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
[TBL] [Abstract][Full Text] [Related]
4. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.
Pez F; Dayan F; Durivault J; Kaniewski B; Aimond G; Le Provost GS; Deux B; Clézardin P; Sommer P; Pouysségur J; Reynaud C
Cancer Res; 2011 Mar; 71(5):1647-57. PubMed ID: 21239473
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
[TBL] [Abstract][Full Text] [Related]
6. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
7. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
[TBL] [Abstract][Full Text] [Related]
9. CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha.
Fox SB; Bragança J; Turley H; Campo L; Han C; Gatter KC; Bhattacharya S; Harris AL
Cancer Res; 2004 Sep; 64(17):6075-81. PubMed ID: 15342390
[TBL] [Abstract][Full Text] [Related]
10. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1.
Wilson JL; Burchell J; Grimshaw MJ
Cancer Res; 2006 Dec; 66(24):11802-7. PubMed ID: 17178876
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
13. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment.
Tafani M; Russo A; Di Vito M; Sale P; Pellegrini L; Schito L; Gentileschi S; Bracaglia R; Marandino F; Garaci E; Russo MA
Cancer Sci; 2010 Apr; 101(4):1014-23. PubMed ID: 20151982
[TBL] [Abstract][Full Text] [Related]
15. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells.
Kattan Z; Minig V; Leroy P; Dauça M; Becuwe P
Breast Cancer Res Treat; 2008 Mar; 108(2):203-15. PubMed ID: 17473980
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.
Peyrol S; Raccurt M; Gerard F; Gleyzal C; Grimaud JA; Sommer P
Am J Pathol; 1997 Feb; 150(2):497-507. PubMed ID: 9033266
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion.
Shyu KG; Hsu FL; Wang MJ; Wang BW; Lin S
Exp Cell Res; 2007 Apr; 313(6):1181-91. PubMed ID: 17335808
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
Yamamoto Y; Ibusuki M; Okumura Y; Kawasoe T; Kai K; Iyama K; Iwase H
Breast Cancer Res Treat; 2008 Aug; 110(3):465-75. PubMed ID: 17805961
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
